SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Venus Remedies informs about press release

08 Dec 2025 Evaluate

Venus Remedies has informed about press release titled - 'Venus Remedies Marks Completion of AMR Ljcensina Milestones with Final $11 Crore Payment'.

The above information is a part of company’s filings submitted to BSE.

Venus Remedies Share Price

1068.40 28.45 (2.74%)
15-Apr-2026 12:46 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1681.50
Dr. Reddys Lab 1218.00
Cipla 1225.00
Zydus Lifesciences 935.80
Lupin 2348.60
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×